Table 3.

Comparison of Findings in Persons with Isolated Pituitary Adenomas by Family History and Presence/Absence of a Germline AIP Pathogenic Variant

CharacteristicsFamilial Isolated Pituitary AdenomaSimplex Somatotropinoma 1
AIP-FIPAXLAGFIPA of unknown cause
Clinical features Age of onset 24-24 yrsInfancy / early childhood40 yrs43 yrs
Average # of affected family members 33-412-3NA
Male-to-female ratio 41:1 to 2:11:21:11:1
Adenoma features Somatotropinomas / somatomammotropinomas70%-80%~100%~50%NA
SizeMacroadenomas in vast majorityPituitary hyperplasia-macroadenomaMajority macroadenoma 5Smaller
AggressivenessMoreVariableMoreLess
Response to treatmentPoorerPoorerPoorerBetter

From: AIP Familial Isolated Pituitary Adenomas

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.